CINCA Syndrome

Also known as: Neonatal-Onset Multisystem Inflammatory Disease (NOMID) / Neonatal Onset Multisystem Inflammatory Disease / NOMID / Neonatal-onset multisystem inflammatory disease / Neonatal-onset multisystemic inflammatory disease / Cryopyrin-associated periodic syndromes / Chronic infantile neurological cutaneous and articular syndrome / Chronic infantile neurological, cutaneous and articular syndrome (disorder) / Chronic Infantile Neurological, Cutaneous, and Articular Syndrome

DrugDrug NameDrug Description
DB00026AnakinraA recombinant form of human interleukin-1 receptor antagonist used in the treatment of rheumatoid arthritis, neonatal-onset multisystem inflammatory disease and deficiency of interleukin-1 receptor antagonist (DIRA).
DrugDrug NamePhaseStatusCount
DB06168Canakinumab3Completed4
DB06168Canakinumab3Terminated1